Related Experiment Video
Updated: Feb 10, 2026

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
[EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.]
Abstract:
The problem of weakening of the action of antiarrhythmic drugs under conditions of activation of the sympathetic nervous system draws increasing attention of researchers. These conditions are frequently encountered in clinical practice in cases of ischemia, myocardial infarction, and in patients with sustained ventricular arrhythmia. In addition, sympathetic, hyperactivity is a characteristic feature of serious cardiovascular diseases including heart failure. The beta-adrenergic stimulation can significantly modulate the electrophysiological action of antiarrhythmic drugs. There are significant differences in the ability of antiarrhythmic drugs to retain efficacy on the background of sympathetic stimulation. Additional administration of beta-blockers to patients with ventricular tachycardia, cardiac insufficiency, cardiomyopathy and patients after myocardial infarction is highly effective and is worth of addition al investigation. The search for drugs whose effect is not affected by sympathetic stimulation is still topical.
More Related Videos
10:24Efficient Differentiation of Postganglionic Sympathetic Neurons using Human Pluripotent Stem Cells under Feeder-free and Chemically Defined Culture Conditions
Published on: May 24, 2020
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Related Concept Videos
The Sympathetic Nervous System
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
CNS Stimulants: Psychedelic Agents